Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preface.

Central nervous system agents in medicinal chemistry·2018
Same author

Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids.

Biologicals : journal of the International Association of Biological Standardization·2015
Same author

Editorial.

Central nervous system agents in medicinal chemistry·2012
Same author

Tenth year.

Central nervous system agents in medicinal chemistry·2010
Same author

Microwave-assisted synthesis of N,N'-diaryl cyanoguanidines.

Organic letters·2005
Same author

Synthesis and neurotrophic activity of nonimmunosuppressant cyclosporin A derivatives.

Bioorganic & medicinal chemistry letters·2004
Same journal

Heterocyclic Scaffolds as Therapeutic Agents in Multiple Sclerosis: Mechanisms and SAR Study.

Central nervous system agents in medicinal chemistry·2026
Same journal

Bioinformatic Identification of Shared Gene Networks Between Weaning- Induced Intestinal Inflammation and Neuroinflammatory-Related Pathways.

Central nervous system agents in medicinal chemistry·2026
Same journal

Fluorinated Gamma-carboline Derivatives as Promising Neuroprotective Candidates. Structure-Activity Relationships.

Central nervous system agents in medicinal chemistry·2026
Same journal

D-galactose-induced Cognitive Impairment: Mechanism, Models and Therapeutic Interventions.

Central nervous system agents in medicinal chemistry·2026
Same journal

Cardiospermum halicacabum: A Scoping Review on its Phytoactives, Neuroprotective, Anti-Inflammatory, and Antioxidant Potential.

Central nervous system agents in medicinal chemistry·2026
Same journal

Therapeutic Insights into Natural Products for Modulating Neurodegenerative Disease Pathways.

Central nervous system agents in medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

The pharmaceutical industry. Preface

Gregory S Hamilton

    Central Nervous System Agents in Medicinal Chemistry
    |March 23, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
    10:33

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

    Published on: December 17, 2021

    Co-Translational Insertion of Membrane Proteins into Preformed Nanodiscs
    08:24

    Co-Translational Insertion of Membrane Proteins into Preformed Nanodiscs

    Published on: November 19, 2020

    Related Experiment Videos

    Last Updated: May 13, 2026

    Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
    09:30

    Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
    10:33

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

    Published on: December 17, 2021

    Co-Translational Insertion of Membrane Proteins into Preformed Nanodiscs
    08:24

    Co-Translational Insertion of Membrane Proteins into Preformed Nanodiscs

    Published on: November 19, 2020